Page last updated: 2024-08-23

bromocriptine and Cardiovascular Pregnancy Complications

bromocriptine has been researched along with Cardiovascular Pregnancy Complications in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (4.76)	18.7374
1990's	1 (2.38)	18.2507
2000's	8 (19.05)	29.6817
2010's	25 (59.52)	24.3611
2020's	6 (14.29)	2.80

Authors

Authors	Studies
Chaparro, S; Hernandez, GA; Ibrahim, M; Kittipibul, V; Mahabir, S; Saint Croix, GR; Trongtorsak, A	1
Mujkanovic, J; Qayyum, AA	1
Adamo, L; Al'Aref, SJ; Asnani, A; Chidambaram, V; Kumar, A; Lau, ES; Majella, MG; Mehta, JL; Ravi, R; Sharma, G; Sinha, S; Sivakumar, RK	1
Bauersachs, J; Berliner, D; König, T; Pfeffer, TJ	1
Demkow, M; Dzielinska, Z; Kryczka, KE	1
Ketineni, S; Potu, KC; Raizada, A; Stys, A; Stys, M	1
Angermann, CE; Bauersachs, J; Berliner, D; Böhm, M; Ehlermann, P; Fischer, D; Franke, A; Haghikia, A; Hilfiker-Kleiner, D; Kindermann, I; Kühl, U; Michels, G; Pfister, R; Podewski, E; Schlitt, A; Schwab, J; Schwarzkopf, M; Sliwa, K; Stangl, V; Vogel-Claussen, J; Westenfeld, R	1
Lüscher, TF	1
Coats, CJ; Dalzell, JR; Jackson, AM; Jhund, PS; Petrie, MC; Walker, NL	1
Bauersachs, J; Berliner, D; Hallbaum, M; Hilfiker-Kleiner, D; König, T; Kühn, C; Napp, LC; Pfeffer, TJ; Schäfer, A; Schmitto, JD; Sieweke, JT; Tongers, J	1
Bauersachs, J; Berliner, D; Böhm, M; Ehlermann, P; Franke, A; Haghikia, A; Hilfiker-Kleiner, D; Kindermann, I; König, T; Kühl, U; Michels, G; Moulig, VA; Pfeffer, T; Pfister, R; Podewski, E; Schwab, J; Schwarzkopf, M; Sliwa, K; Stangl, V; Vogel-Claussen, J; Westenfeld, R; Zwadlo, C	1
Afilalo, J; Avram, R; Bélisle, P; Bibas, L; Couture, E; Descarries, L; Desplantie, O; Diaz, A; Ducharme, A; Farand, P; Fortier, A; Harvey, L; Jolicoeur, EM; Ly, HQ; Malhamé, I; Marquis-Gravel, G; Pacheco, C; Poulin, A; Pranno, N; Rey, E; Sénéchal, M; Simard, F; Tournoux, F; Tran, D; Tremblay-Gravel, M	1
A Kamiya, C; Eto, K; Fukui, D; Fukumoto, Y; Furusho, A; Kumanomido, J; Morikawa, N; Nakayoshi, T; Nishida, N; Nishihara, M; Watanabe, M; Yoshimura, H	1
Dłużniewski, M; Grzywanowska-Łaniewska, I; Lewandowski, A; Syska-Sumińska, J; Wsól, A; Załęska-Zydlewska, I	1
Cemin, R; Daves, M; Donazzan, L; Janardhanan, R	1
Hamada, T; Idei, M; Sumikura, H	1
Angermann, CE; Bauersachs, J; Berliner, D; Böhm, M; Fischer, D; Haghikia, A; Hilfiker-Kleiner, D; Podewski, E; Röntgen, P; Sonnenschein, K	1
Avram, R; Desplantie, O; Ducharme, A; Jolicoeur, EM; Marquis-Gravel, G; Tremblay-Gravel, M	1
Cardona-Guarache, R; Kron, J	1
Bouabdallaoui, N; Demondion, P; Ennezat, PV; Le Jemtel, TH; Lebreton, G; Mouquet, F	1
Arany, Z; Elkayam, U	1
Nicholls, M	1
Dietz, R; Dudenhausen, JW; Elgeti, T; Habedank, D; Haverkamp, W; Kühnle, Y	1
Emons, G; Hilfiker-Kleiner, D; Jahns, BG; Pieske, B; Stein, W	1
Bretler, DM; Gislason, GH; Hansen, PR; Jørgensen, CH; Olesen, JB	1
de Groote, P; Lamblin, N; Mouquet, F	1
Biteker, M; Duran, NE; Ozkan, M	1
Swalve-Bordeaux, S	1
Becker, A; Blauwet, L; Hilfiker-Kleiner, D; Labidi, S; Libhaber, E; McMurray, J; Sliwa, K; Smedema, JP; Struhman, I; Struman, I; Tibazarwa, K; Yamac, H	1
Elkayam, U; Goland, S	1
Bultmann, I; Hilfiker-Kleiner, D; Sliwa, K; Yamac, H	1
Abe, T; Akira, S; Amano, I; Nakai, A; Sawa, R; Takeshita, T	1
Alfirevic, Z; Carlin, AJ; Gyte, GM	1
Czerski, T; Piotrowska-Kownacka, D	1
Arany, Z; Bauersachs, J; Burke, SD; del Monte, F; Farrell, C; Hacker, MR; Hess, P; Hilfiker-Kleiner, D; Jang, C; Karumanchi, SA; Khankin, EV; Koulisis, N; Liu, L; Mahmood, F; Mitchell, J; Patten, IS; Rana, S; Rhee, JS; Rowe, GC; Shahul, S; Tudorache, I	1
Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S	1
Hilfiker-Kleiner, D; Hoch, M; Podewski, E; Sliwa, K; Struman, I	1
Leinwand, LA	1
Ansari, A; Balligand, JL; Bonda, T; Desjardins, F; Doerries, C; Drexler, H; Forster, O; Heusch, G; Hilfiker, A; Hilfiker-Kleiner, D; Kaminski, K; Klein, G; Landmesser, U; Luchtefeld, M; Nguyen, NQ; Podewski, E; Poli, V; Quint, A; Schaefer, A; Schneider, MD; Schulz, R; Sliwa, K; Struman, I; Zschemisch, NH	1
Jenkins, DM; Soltan, MH	1
Correia, J; Hopp, L; Iffy, L; O'Donnell, J	1
Duhring, JL; Ruch, A	1

Reviews

13 review(s) available for bromocriptine and Cardiovascular Pregnancy Complications

Article	Year
Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis. Heart failure reviews, 2022, Volume: 27, Issue:2 Topics: Bromocriptine; Cardiomyopathies; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Stroke Volume; Ventricular Function, Left	2022
Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis. Current problems in cardiology, 2023, Volume: 48, Issue:2 Topics: Bromocriptine; Cardiomyopathies; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Stroke Volume; Ventricular Function, Left	2023
Peripartum cardiomyopathy - a cardiovascular disease in pregnancy and puerperium. The actual state of knowledge, challenges, and perspectives. Ginekologia polska, 2021, Volume: 92, Issue:2 Topics: Adult; Bacterial Outer Membrane Proteins; Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Female; Health Knowledge, Attitudes, Practice; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Treatment Outcome	2021
Peripartum Cardiomyopathy: Literature Review. South Dakota medicine : the journal of the South Dakota State Medical Association, 2016, Volume: 69, Issue:5 Topics: Adrenergic beta-Antagonists; Anticoagulants; Bromocriptine; Cardiomyopathy, Dilated; Delivery, Obstetric; Diuretics; Dopamine Agonists; Electric Countershock; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors	2016
Peripartum cardiomyopathy: moving towards a more central role of genetics. Current cardiology reviews, 2013, Volume: 9, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bromocriptine; Cardiomyopathy, Dilated; Echocardiography; Female; Genetic Predisposition to Disease; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Twin; Prognosis; Risk Factors; Treatment Outcome	2013
[Anesthetic management of parturients with peripartum cardiomyopathy]. Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:1 Topics: Analgesia, Obstetrical; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; Animals; Bromocriptine; Cardiomyopathies; Cesarean Section; Female; Heart Transplantation; Humans; Monitoring, Intraoperative; Mutation; Oxidative Stress; Perioperative Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin	2014
The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies. The Canadian journal of cardiology, 2015, Volume: 31, Issue:12 Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Puerperal Disorders; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Survival Rate; Ventricular Dysfunction, Left	2015
Current knowledge and recent development on management of peripartum cardiomyopathy. European heart journal. Acute cardiovascular care, 2017, Volume: 6, Issue:4 Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hormone Antagonists; Humans; Incidence; Natriuretic Peptide, Brain; Oxidative Stress; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Radiography, Thoracic; Ventricular Dysfunction, Left	2017
Peripartum Cardiomyopathy. Circulation, 2016, Apr-05, Volume: 133, Issue:14 Topics: Bromocriptine; Cardiomyopathies; Cardiovascular Agents; Disease Susceptibility; Female; Heart Failure; Heart Transplantation; Hormones; Humans; Hypertension; Incidence; Infant, Newborn; Lactation; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Multiple; Puerperal Disorders	2016
Prolactin: a new therapeutic target in peripartum cardiomyopathy. Heart (British Cardiac Society), 2010, Volume: 96, Issue:17 Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Hormone Antagonists; Humans; Mice; Oxidative Stress; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders	2010
Interventions for treating peripartum cardiomyopathy to improve outcomes for women and babies. The Cochrane database of systematic reviews, 2010, Sep-08, Issue:9 Topics: Acute Disease; Bromocriptine; Cardiotonic Agents; Female; Heart Failure; Humans; Infant; Pilot Projects; Postoperative Period; Pregnancy; Pregnancy Complications, Cardiovascular	2010
16-kDa prolactin and bromocriptine in postpartum cardiomyopathy. Current heart failure reports, 2012, Volume: 9, Issue:3 Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Oxidative Stress; Peptide Fragments; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders	2012
Postpartum myocardial infarction in a patient receiving bromocriptine. Obstetrics and gynecology, 1989, Volume: 74, Issue:3 Pt 2 Topics: Adult; Bromocriptine; Female; Humans; Hypertension; Myocardial Infarction; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders	1989

Trials

5 trial(s) available for bromocriptine and Cardiovascular Pregnancy Complications

Article	Year
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. European heart journal, 2017, Sep-14, Volume: 38, Issue:35 Topics: Adult; Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Drug Administration Schedule; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Recovery of Function; Treatment Outcome; Ventricular Dysfunction, Left	2017
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction. Clinical research in cardiology : official journal of the German Cardiac Society, 2019, Volume: 108, Issue:3 Topics: Bromocriptine; Cardiomyopathies; Dose-Response Relationship, Drug; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Hormone Antagonists; Humans; Magnetic Resonance Imaging, Cine; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Right	2019
Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy. Clinical research in cardiology : official journal of the German Cardiac Society, 2015, Volume: 104, Issue:11 Topics: Adult; Bromocriptine; Cardiomyopathies; Female; Humans; Multicenter Studies as Topic; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Research Design; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult	2015
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation, 2010, Apr-06, Volume: 121, Issue:13 Topics: Acute Disease; Adolescent; Adult; Blood Pressure; Bromocriptine; Cardiomyopathies; Cathepsin D; Female; Heart Failure; Hormone Antagonists; Humans; Infant, Newborn; Middle Aged; Parturition; Pilot Projects; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prolactin; Thromboembolism; Treatment Outcome; Ultrasonography; Ventricular Function, Left; Young Adult	2010
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell, 2007, Feb-09, Volume: 128, Issue:3 Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Heart Transplantation; Humans; Hypertrophy, Left Ventricular; Lactation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Oxidative Stress; Peptide Fragments; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor	2007

Other Studies

24 other study(ies) available for bromocriptine and Cardiovascular Pregnancy Complications

Article	Year
Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy. Current cardiology reviews, 2023, Volume: 19, Issue:2 Topics: Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Randomized Controlled Trials as Topic; Stroke Volume; Ventricular Function, Left	2023
[Peripartum Cardiomyopathy]. Deutsche medizinische Wochenschrift (1946), 2022, Volume: 147, Issue:23 Topics: Animals; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; Shock, Cardiogenic; Ventricular Dysfunction, Left	2022
An update on cardiomyopathies: immune-mediated diseases, sarcoidosis, and peripartum and hypertrophic cardiomyopathies during pregnancy. European heart journal, 2017, 09-14, Volume: 38, Issue:35 Topics: Adult; Bromocriptine; Cardiomyopathy, Hypertrophic; Female; Hormone Antagonists; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Sarcoidosis; Stroke Volume; Ventricular Function, Left	2017
Peripartum cardiomyopathy: diagnosis and management. Heart (British Cardiac Society), 2018, Volume: 104, Issue:9 Topics: Anticoagulants; Bromocriptine; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotonic Agents; Contraception; Defibrillators; Delayed Diagnosis; Delivery, Obstetric; Drug Substitution; Female; Forecasting; Heart Transplantation; Heart-Assist Devices; Hormone Antagonists; Humans; Peripartum Period; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Diagnosis; Puerperal Disorders; Recovery of Function; Risk Factors; Treatment Outcome	2018
Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy. European heart journal. Acute cardiovascular care, 2020, Volume: 9, Issue:2 Topics: Adult; Bromocriptine; Cardiomyopathies; Combined Modality Therapy; Extracorporeal Membrane Oxygenation; Female; Heart Failure; Hormone Antagonists; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Shock, Cardiogenic; Stroke Volume; Survival Rate; Treatment Outcome; Ventricular Function, Left	2020
The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study. ESC heart failure, 2019, Volume: 6, Issue:1 Topics: Adult; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Recovery of Function; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left	2019
The Use of Bromocriptine for Peripartum Cardiomyopathy after Twin Delivery via Oocyte Donation. Internal medicine (Tokyo, Japan), 2019, Feb-15, Volume: 58, Issue:4 Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Middle Aged; Oocyte Donation; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left	2019
[Patient with sudden cardiac arrest, peripartum cardiomyopathy and pulmonary embolism]. Kardiologia polska, 2013, Volume: 71, Issue:7 Topics: Adult; Bromocriptine; Death, Sudden, Cardiac; Dopamine Agonists; Dyspnea; Female; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Pulmonary Embolism; Time Factors; Treatment Outcome	2013
Treatment of Peripartum Cardiomyopathy: A Call to Action. The Canadian journal of cardiology, 2015, Volume: 31, Issue:12 Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Pyridazines	2015
An airport meeting that led to bromocriptine use in peripartum cardiomyopathy. European heart journal, 2016, 11-21, Volume: 37, Issue:44 Topics: Airports; Animals; Bromocriptine; Cardiomyopathies; Female; Humans; Mice; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders	2016
Recovery from peripartum cardiomyopathy after treatment with bromocriptine. European journal of heart failure, 2008, Volume: 10, Issue:11 Topics: Adult; Bromocriptine; Cardiomyopathies; Female; Follow-Up Studies; Heart Failure; Hormone Antagonists; Humans; Infant, Newborn; Magnetic Resonance Imaging; Male; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Recovery of Function	2008
Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion. American journal of obstetrics and gynecology, 2008, Volume: 199, Issue:4 Topics: Adult; Bromocriptine; Cardiomyopathies; Cathepsin D; Female; Heart Failure; HELLP Syndrome; Hormone Antagonists; Humans; Myocardium; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin	2008
[Peripartum cardiomyopathy]. Ugeskrift for laeger, 2009, Jan-05, Volume: 171, Issue:1-2 Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors	2009
Indication for bromocriptine in peripartum cardiomyopathy. European journal of heart failure, 2009, Volume: 11, Issue:2 Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular	2009
The role of bromocriptine in peripartum cardiomyopathy. American journal of obstetrics and gynecology, 2009, Volume: 201, Issue:2 Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular	2009
Correspondence (letter to the editor): Case numbers are tiny. Deutsches Arzteblatt international, 2009, Volume: 106, Issue:11 Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular	2009
Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation, 2010, Apr-06, Volume: 121, Issue:13 Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular	2010
Recovery from peripartum cardiomyopathy in a Japanese woman after administration of bromocriptine as a new treatment option. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2010, Volume: 77, Issue:4 Topics: Asian People; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Female; Humans; Natriuretic Peptide, Brain; Pleural Effusion; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Edema; Radiography, Thoracic; Time Factors; Ultrasonography	2010
[Pulmonary oedema--as first symptom of the postpartum cardiomyopathy. The role of cardiac MRI in diagnostic process]. Kardiologia polska, 2011, Volume: 69, Issue:9 Topics: Bromocriptine; Cardiomyopathies; Cesarean Section; Diagnosis, Differential; Eclampsia; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Edema; Radiography; Young Adult	2011
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature, 2012, May-09, Volume: 485, Issue:7398 Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Neovascularization, Pathologic; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Trans-Activators; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1	2012
[Gender effect on cardiomyopathy]. Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:6 Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome	2012
Molecular events underlying pregnancy-induced cardiomyopathy. Cell, 2007, Feb-09, Volume: 128, Issue:3 Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor	2007
Plasma prolactin and puerperal blood pressure. British journal of obstetrics and gynaecology, 1980, Volume: 87, Issue:7 Topics: Blood Pressure; Breast Feeding; Bromocriptine; Female; Humans; Hypertension; Lactation; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin	1980
Severe cardiac dysrhythmia in patients using bromocriptine postpartum. American journal of therapeutics, 1998, Volume: 5, Issue:2 Topics: Adult; Arrhythmias, Cardiac; Bromocriptine; Cardiomyopathies; Causality; Dopamine Agonists; Electrocardiography; Fatal Outcome; Female; Humans; Hypertension; Lactation; Long QT Syndrome; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders	1998